These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7927490)

  • 1. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice.
    Mengozzi M; Fantuzzi G; Faggioni R; Marchant A; Goldman M; Orencole S; Clark BD; Sironi M; Benigni F; Ghezzi P
    Immunology; 1994 Jun; 82(2):207-10. PubMed ID: 7927490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock.
    Gadina M; Bertini R; Mengozzi M; Zandalasini M; Mantovani A; Ghezzi P
    J Exp Med; 1991 Jun; 173(6):1305-10. PubMed ID: 2033366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers.
    Bleeker MW; Netea MG; Kullberg BJ; Van der Ven-Jongekrijg J; Van der Meer JW
    Immunology; 1997 Aug; 91(4):548-52. PubMed ID: 9378493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity.
    Benigni F; Villa P; Demitri MT; Sacco S; Sipe JD; Lagunowich L; Panayotatos N; Ghezzi P
    Mol Med; 1995 Jul; 1(5):568-75. PubMed ID: 8529123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.
    Di Santo E; Sironi M; Pozzi P; Gnocchi P; Isetta AM; Delvaux A; Goldman M; Marchant A; Ghezzi P
    Neuroimmunomodulation; 1995; 2(3):149-54. PubMed ID: 8646564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of chlorpromazine against the lethality of interleukin 1 in adrenalectomized or actinomycin D-sensitized mice.
    Bertini R; Bianchi M; Mengozzi M; Ghezzi P
    Biochem Biophys Res Commun; 1989 Dec; 165(3):942-6. PubMed ID: 2692568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline.
    Ohtsuka H; Higuchi T; Matsuzawa H; Sato H; Takahashi K; Takahashi J; Yoshino TO
    J Vet Med Sci; 1997 Nov; 59(11):1075-7. PubMed ID: 9409530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality.
    Gatti S; Faggioni R; Echtenacher B; Ghezzi P
    Clin Exp Immunol; 1993 Mar; 91(3):456-61. PubMed ID: 8443968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro.
    Zinetti M; Galli G; Demitri MT; Fantuzzi G; Minto M; Ghezzi P; Alzani R; Cozzi E; Fratelli M
    Immunology; 1995 Nov; 86(3):416-21. PubMed ID: 8550079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo.
    Tarazona R; González-García A; Zamzami N; Marchetti P; Frechin N; Gonzalo JA; Ruiz-Gayo M; van Rooijen N; Martínez C; Kroemer G
    J Immunol; 1995 Jan; 154(2):861-70. PubMed ID: 7814889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice.
    Bertini R; Garattini S; Delgado R; Ghezzi P
    Immunology; 1993 Jun; 79(2):217-9. PubMed ID: 8102118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.
    Villa P; Sartor G; Angelini M; Sironi M; Conni M; Gnocchi P; Isetta AM; Grau G; Buurman W; van Tits LJ
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):549-53. PubMed ID: 8548533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo.
    Endres S; Whitaker RE; Ghorbani R; Meydani SN; Dinarello CA
    Immunology; 1996 Feb; 87(2):264-70. PubMed ID: 8698389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production.
    Peristeris P; Clark BD; Gatti S; Faggioni R; Mantovani A; Mengozzi M; Orencole SF; Sironi M; Ghezzi P
    Cell Immunol; 1992 Apr; 140(2):390-9. PubMed ID: 1544168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of interleukin-2-induced hydrothoraxy in mice: protective effect of endotoxin tolerance and dexamethasone and possible role of reactive oxygen intermediates.
    Faggioni R; Allavena P; Cantoni L; Carelli M; Demitri MT; Delgado R; Gatti S; Gnocchi P; Isetta AM; Paganin C
    J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):194-201. PubMed ID: 8032542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron.
    Bertini R; Bianchi M; Erroi A; Villa P; Ghezzi P
    J Leukoc Biol; 1989 Sep; 46(3):254-62. PubMed ID: 2788206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo.
    Bertini R; Mengozzi M; Bianchi M; Sipe JD; Ghezzi P
    Int J Immunopharmacol; 1991; 13(8):1085-90. PubMed ID: 1814847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T; Hisadome M; Komatsu H
    J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in mice.
    Ghezzi P; Sipe JD
    Lymphokine Res; 1988; 7(2):157-66. PubMed ID: 3261378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.